| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |